Influenza in solid organ transplant recipients;Gripe en receptores de trasplantes de órganos sólidos

Annals of Pharmacotherapy

Volumn 46, Issue 2, 2012, Pages 255-264

  Martin, Spencer T ^a   Torabi, Mina J ^b   Gabardi, Steven ^c  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b YALE NEW HAVEN HOSPITAL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Heart transplant; Influenza; Liver transplant; Lung transplant; Novel influenza A H1N1; Renal transplant; Solid organ transplant

Indexed keywords

ANTIVIRUS AGENT; AZATHIOPRINE; IMMUNOSUPPRESSIVE AGENT; INFLUENZA VACCINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OSELTAMIVIR; PEGINTERFERON ALPHA; PERAMIVIR; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; VIRUS ANTIBODY; ZANAMIVIR;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ACUTE GRAFT REJECTION; ADJUVANT THERAPY; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANOREXIA; ANTIBODY RESPONSE; ANTIVIRAL THERAPY; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CARDIAC GRAFT REJECTION; CHEMOPROPHYLAXIS; CHILL; CHRONIC GRAFT REJECTION; CLINICAL FEATURE; CONJUNCTIVITIS; COUGHING; DIARRHEA; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG EXCRETION; DRUG FEVER; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DRUG METABOLISM; DRUG PROTEIN BINDING; EPISTAXIS; FATIGUE; GRAFT RECIPIENT; HEART TRANSPLANTATION; HEPATITIS B; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; INFLUENZA A (H1N1); INFLUENZA VACCINATION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; MYALGIA; NAUSEA; ORGAN DONOR; ORGAN TRANSPLANTATION; PANDEMIC; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; REVIEW; SIDE EFFECT; SORE THROAT; STEROID THERAPY; TIME TO MAXIMUM PLASMA CONCENTRATION; VIRUS IMMUNITY; VIRUS TRANSMISSION; VOMITING;

ANTIVIRAL AGENTS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; ORGAN TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS;

EID: 84856991681     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1Q436     Document Type: Review

References (59)

1. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003;289:179-86.
2. Cox NJ, Subbarao K. Influenza. Lancet 1999;354:1277-82.
3. Centers for Disease Control and Prevention. H1N1 Flu., 2010. www.cdc. gov/H1N1flu/estimates/April_February_13.htm (accessed 2011 Jun 27).
4. Brankston G, Gitterman L, Hirji Z, Lemieux C, Gardam M. Transmission of influenza A in human beings. Lancet Infect Dis 2007;7:257-65.
5. Hall CB. The spread of influenza and other respiratory viruses: complexities and conjectures. Clin Infect Dis 2007;45:353-9.
6. Hayden FG, Fritz R, Lobo MC, Alvord W, Strober W, Straus SE. Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J Clin Invest 1998;101:643-9.
7. Frank AL, Taber LH, Wells CR, Wells JM, Glezen WP, Paredes A. Patterns of shedding of myxoviruses and paramyxoviruses in children. J Infect Dis 1981;144:433-41.
8. Lee I, Barton TD. Viral respiratory tract infections in transplant patients: epidemiology, recognition and management. Drugs 2007;67:1411-27.
9. Vilchez RA, McCurry K, Dauber J, et al. Influenza virus infection in adult solid organ transplant recipients. Am J Transplant 2002;2:287-91.
10. Gottlieb J, Schulz TF, Welte T, et al. Community-acquired respiratory viral infections in lung transplant recipients: a single season cohort study. Transplantation 2009;87:1530-7.
11. Milstone AP, Brumble LM, Barnes J, et al. A single-season prospective study of respiratory viral infections in lung transplant recipients. Eur Respir J 2006;28:131-7.
12. Centers for Disease Control and Prevention. 2009 H1N1 early outbreak and disease characteristics, 2009. www.cdc.gov/h1n1flu/surveillanceqa. htm (accessed 2011 Jun 27).
13. Kumar D, Michaels MG, Morris MI, et al. Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study. Lancet Infect Dis 2010;10:521-6.
14. Smud A, Nagel CB, Madsen E, et al. Pandemic influenza A/H1N1 virus infection in solid organ transplant recipients: a multicenter study. Transplantation 2010;90:1458-62.
15. Low CY, Kee T, Chan KP, et al. Pandemic (H1N1) 2009 infection in adult solid organ transplant recipients in Singapore. Transplantation 2010;90:1016-21.
16. Ng BJ, Glanville AR, Snell G, et al. The impact of pandemic influenza A H1N1 2009 on Australian lung transplant recipients. Am J Transplant 2011;11:568-74.
17. Fox BD, Raviv Y, Rozengarten D, Rusanov V, Bakal I, Kramer MR. Pandemic influenza (H1N1): impact on lung transplant recipients and candidates. J Heart Lung Transplant 2010;29:1034-8.
18. Kumar R, Kamdar D, Madden L, et al. Th1/Th2 cytokine imbalance in meningioma, anaplastic astrocytoma and glioblastoma multiforme patients. Oncol Rep 2006;15:1513-6.
19. Stucchi RS, Boin IF, Angerami RN, et al. Correlations between A/H1N1 influenza and acute cellular rejection in liver transplantation patients. Transplant Proc 2010;42:4184-6.
20. Le Page AK, Kainer G, Glanville AR, Tu E, Bhonagiri D, Rawlinson WD. Influenza B virus transmission in recipients of kidney and lung transplants from an infected donor. Transplantation 2010;90:99-102.
21. Meylan PR, Aubert JD, Kaiser L. Influenza transmission to recipient through lung transplantation. Transpl Infect Dis 2007;9:55-7.
22. Lattes R, Jacob N, de la Fuente J, Fragale G, Massari P. Pandemic influenza A/H1N1 and organ donation. Transpl Infect Dis 2010;12:169-72.
23. Al Aklabi MM, Weinkauf JG, Humar A, Ghorpade N. Successful bilateral lung transplantation in a patient with end-stage lung disease and positive novel influenza virus (H1N1). J Heart Lung Transplant 2010;29:898-9.
24. Duchini A, Goss JA, Karpen S, Pockros PJ. Vaccinations for adult solidorgan transplant recipients: current recommendations and protocols. Clin Microbiol Rev 2003;16:357-64.
25. Guidelines for vaccination of solid organ transplant candidates and recipients. Am J Transplant 2004;4(suppl 10):160-3.
26. Gangappa S, Kokko KE, Carlson LM, et al. Immune responsiveness and protective immunity after transplantation. Transpl Int 2008;21:293-303.
27. Candon S, Thervet E, Lebon P, et al. Humoral and cellular immune responses after influenza vaccination in kidney transplant recipients. Am J Transplant 2009;9:2346-54.
28. Scharpe J, Evenepoel P, Maes B, et al. Influenza vaccination is efficacious and safe in renal transplant recipients. Am J Transplant 2008; 8:332-7.
29. Keshtkar-Jahromi M, Argani H, Rahnavardi M, et al. Antibody response to influenza immunization in kidney transplant recipients receiving either azathioprine or mycophenolate: a controlled trial. Am J Nephrol 2008;28:654-60.
30. Sanchez-Fructuoso AI, Prats D, Naranjo P, et al. Influenza virus immunization effectivity in kidney transplant patients subjected to two different triple-drug therapy immunosuppression protocols: mycophenolate versus azathioprine. Transplantation 2000;69:436-9.
31. Birdwell KA, Ikizler MR, Sannella EC, et al. Decreased antibody response to influenza vaccination in kidney transplant recipients: a prospective cohort study. Am J Kidney Dis 2009;54:112-21.
32. Salles MJ, Sens YA, Boas LS, Machado CM. Influenza virus vaccination in kidney transplant recipients: serum antibody response to different immunosuppressive drugs. Clin Transplant 2010;24:E17-23.
33. Nailescu C, Xu X, Zhou H, et al. Influenza vaccine after pediatric kidney transplant: a Midwest Pediatric Nephrology Consortium study. Pediatr Nephrol 2011;26:459-67.
34. Barrou B, Pouteil C, Meiffredy V, et al. Safety and efficacy of an inactivated, unadjuvanted vaccine against the novel influenza a variant (H1N1v) in renal transplant recipients (INSERM C09-32, Transfluvac Study) (abstract 160). American Transplant Congress, Philadelphia, PA, April 30-May 4, 2011.
35. Hauser I, Roessel D, Gauer S, et al. Efficay and safety of H1N1 vaccination in renal transplant recipients and chronic dialysis patients (abstract 860). American Transplant Congress, Philadelphia, PA, April 30-May 4, 2011.
36. Crespo M, Collado S, Mir M, et al. Response to a 2009 pandemic influenza virus vaccine in kidney transplant (KT) patients (abstract 872). American Transplant Congress, Philadelphia, PA, April 30-May 4, 2011.
37. Mazzone PJ, Mossad SB, Mawhorter SD, Mehta AC, Schilz RJ, Maurer JR. The humoral immune response to influenza vaccination in lung transplant patients. Eur Respir J 2001;18:971-6.
38. Hayney MS, Welter DL, Francois M, Reynolds AM, Love RB. Influenza vaccine antibody responses in lung transplant recipients. Prog Transplant 2004;14:346-51.
39. Fraund S, Wagner D, Pethig K, Drescher J, Girgsdies OE, Haverich A. Influenza vaccination in heart transplant recipients. J Heart Lung Transplant 1999;18:220-5.
40. Kimball P, Verbeke S, Tolman D. Influenza vaccination among heart transplant recipients. Transplant Proc 2001;33:1785-6.
41. Altamirano-Diaz L, West L, Humar A, et al. Early post-transplant vaccination with pandemic influenza A/H1N1 vaccine in pediatric heart transplant recipients. Pediatr Transplant 2011;15:172-5.
42. Burbach G, Bienzle U, Stark K, et al. Influenza vaccination in liver transplant recipients. Transplantation 1999;67:753-5.
43. Duchini A, Hendry RM, Nyberg LM, Viernes ME, Pockros PJ. Immune response to influenza vaccine in adult liver transplant recipients. Liver Transpl 2001;7:311-3.
44. Gaeta GB, Pariani E, Amendola A, et al. Influenza vaccination in patients with cirrhosis and in liver transplant recipients. Vaccine 2009;27: 3373-5.
45. Kenney RT, Frech SA, Muenz LR, Villar CP, Glenn GM. Dose sparing with intradermal injection of influenza vaccine. N Engl J Med 2004;351: 2295-301.
46. Belshe RB, Newman FK, Cannon J, et al. Serum antibody responses after intradermal vaccination against influenza. N Engl J Med 2004;351: 2286-94.
47. Manuel O, Humar A, Chen MH, et al. Immunogenicity and safety of an intradermal boosting strategy for vaccination against influenza in lung transplant recipients. Am J Transplant 2007;7:2567-72.
48. Morelon E, Noble CP, Daoud S, et al. Immunogenicity and safety of intradermal influenza vaccination in renal transplant patients who were non-responders to conventional influenza vaccination. Vaccine 2010;28: 6885-90.
49. Kumar D, Morris MI, Kotton CN, et al. Guidance on novel influenza A/H1N1 in solid organ transplant recipients. Am J Transplant 2010;10: 18-25.
50. Centers for Disease Control and Prevention. Antiviral agents for the treatment and chemoprophylaxis of influenza-recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011;60:1-24.
51. Harper SA, Bradley JS, Englund JA, et al. Seasonal influenza in adults and children-diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Disease Society of America. Clin Infect Dis 2009;48:1003-32.
52. Danziger-Isakov LA, Husain S, Mooney ML, et al. The novel 2009 H1N1 influenza pandemic: unique considerations for programs in cardiothoracic transplantation. J Heart Lung Transplant 2009;28:1341-7.
53. Moscona A. Neuraminidase inhibitors for influenza. N Engl J Med 2005;353:1363-73.
54. Treanor JJ, Hayden FG, Vrooman PS, et al. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group. JAMA 2000;283:1016-24.
55. Hayden FG, Atmar RL, Schilling M, et al. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza. N Engl J Med 1999;341:1336-43.
56. Ison MG, Sharma A, Shepard JA, Wain JC, Ginns LC. Outcome of influenza infection managed with oseltamivir in lung transplant recipients. J Heart Lung Transplant 2008;27:282-8.
57. Watcharananan SP, Suwatanapongched T, Wacharawanichkul P, Chantratitaya W, Mavichak V, Mossad SB. Influenza A/H1N1 2009 pneumonia in kidney transplant recipients: characteristics and outcomes following high-dose oseltamivir exposure. Transpl Infect Dis 2010;12: 127-31.
58. Dohna-Schwake C, Schweiger B, Felderhoff-Muser U, et al. Severe H1N1 infection in a pediatric liver transplant recipient treated with intravenous zanamivir: efficacy and complications. Transplantation 2010;90:223-4.
59. Mancuso CE, Gabay MP, Steinke LM, VanOsdol SJ. Peramivir: an intravenous neuraminidase inhibitor for the treatment of 2009 H1N1 influenza. Ann Pharmacother 2010;44:1240-9. DOI 10.1345/aph.1P031